Multidisciplinary cardiac case conference
Multidisciplinary cardiac case conference has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Oct 26, 2026: “Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations”.
1 paper studies it4 findingsUpdated
1 new paper in 30 daysSee all 1 papers on multidisciplinary cardiac case conference
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Quadruple therapy increased from 45% to 82% (p<0.001).”
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
What did studies of multidisciplinary cardiac case conference find?
4Studies of multidisciplinary cardiac case conference measured 4 outcomes, among them medication safety outcomes, renal function and left ventricular ejection fraction.
Medication safety outcomes
no changein humans1
1 study
Medication safety outcomes
no changein humans1
Multidisciplinary cardiac case conference was not clearly linked with medication safety outcomes in humans (heart failure with reduced ejection fraction).
“There was no significant change in hyperkalaemia, renal dysfunction nor admissions related to medication side effects.”
Humansheart failure with reduced ejection fractionn = 89
ESC Congress 2026 abstract
Renal function
no changein humans1
1 study
Renal function
no changein humans1
Multidisciplinary cardiac case conference was not clearly linked with renal function in humans (eGFR <45) (GFR +0.3; units not stated).
“Patients with eGFR <45 (n=27) had stable renal function (GFR +0.3, p=0.87)”
HumanseGFR <45kidneyn = 27
ESC Congress 2026 abstract
Left ventricular ejection fraction
upin humans1
1 study
Left ventricular ejection fraction
upin humans1
Multidisciplinary cardiac case conference is linked with higher left ventricular ejection fraction in humans (heart failure with reduced ejection fraction) (+12.1±10.8%).
“Mean LVEF improved +12.1±10.8% (p<0.001)”
Humansheart failure with reduced ejection fractionleft ventriclen = 89
ESC Congress 2026 abstract
Quadruple therapy achievement
upin humans1
1 study
Quadruple therapy achievement
upin humans1
Multidisciplinary cardiac case conference is linked with higher quadruple therapy achievement in humans (heart failure with reduced ejection fraction) (45% to 82%).
“Quadruple therapy increased from 45% to 82% (p<0.001).”
Humansheart failure with reduced ejection fractionn = 89
ESC Congress 2026 abstract